4.8 Article

Dual-Modal Therapeutic Role of the Lactate Oxidase-Embedded Hierarchical Porous Zeolitic Imidazolate Framework as a Nanocatalyst for Effective Tumor Suppression

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 12, Issue 29, Pages 32278-32288

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.0c05783

Keywords

antitumor therapy; catalytic nanosystem; lactic acid; reactive oxygen species; tumor microenvironments

Funding

  1. China Scholarship Council [201806315005, 201703170071]
  2. National Science Foundation of China [U190420008, 31870994]
  3. Outstanding Youth Development Program in Third Military Medical University

Ask authors/readers for more resources

The increasing evidence supports the fact that lactate in the tumor microenvironment (TME) plays a vital role in tumor proliferation, metastasis, and recurrence, which in turn is emerging as one of the most interesting molecular targets for tumor treatment. Here, hierarchical porous zeolitic imidazolate framework-8 (ZIF-8) as the nanocarrier is fabricated to simultaneously load lactate oxidase (LOD) and Fe3O4 nanoparticles (NPs), called LOD & Fe3O4@ZIF-8 NPs (LFZ NPs), for tumor therapy. On one hand, the sharp consumption of lactate in the TME by LOD will change the essential soil where tumor cells live so as to suppress tumor rapid growth. On the other hand, hydrogen peroxide (H2O2) is produced in the TME from the oxidation of lactate catalyzed by LOD and subsequently converted to highly toxic hydroxyl radicals ((OH)-O-center dot) catalyzed by Fe3O4 NPs via Fenton-like reactions to kill tumor cells. Based on they endogenous catalysis, this dual-modal strategy of tumor therapy based on lactate is simple, safe, and effective, which deserves to be well concerned.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available